Search results
Results from the Go Local Guru Content Network
MYmta is a mobile application-based passenger information display system developed by the Metropolitan Transportation Authority (MTA) of New York City. A beta version of the app was launched on July 2, 2018, and as of June 2019 [update] is still undergoing beta testing .
The app is still in Beta testing, but will eventually succeed the MYmta app. The new app has schedules and service alerts for subways, buses, Long Island Rail Road and Metro-North Railroad all...
The cellphone-friendly website and "MYmta" app, currently in a beta test phase, show straphangers real-time subway, bus and commuter rail information that has been housed in separate apps.
Beta 2 blocker. Beta 2 blocker should be avoided for patients with asthma, COPD as it causes bronchoconstriction. It may also increase the chance of hypoglycemic comas in diabetic patients. Beta 3 blocker. Due to the relatively limited study on beta-3 receptor, there is not much development of beta-3 blocker.
The Metropolitan Transportation Authority (MTA) provides local and express bus, subway, and commuter rail service in Greater New York, and operates multiple toll bridges and tunnels in New York City. The Metropolitan Transportation Authority ( MTA) is a public benefit corporation responsible for public transportation in the New York City ...
Propranolol is a non-selective β-adrenergic receptor antagonist, or beta blocker; that is, it blocks the action of epinephrine (adrenaline) and norepinephrine (noradrenaline) at both β 1-and β 2-adrenergic receptors.
Beta blockers, also spelled β-blockers, are a class of medications that are predominantly used to manage abnormal heart rhythms ( arrhythmia ), and to protect the heart from a second heart attack after a first heart attack ( secondary prevention ). [1]
Metoprolol is a beta blocker, or an antagonist of the β-adrenergic receptors. It is specifically a selective antagonist of the β 1-adrenergic receptor and has no intrinsic sympathomimetic activity. Metoprolol exerts its effects by blocking the action of certain neurotransmitters, specifically adrenaline and noradrenaline.
Bisoprolol, sold under the brand name Zebeta among others, is a beta blocker which is selective for the beta-1 receptor and used for cardiovascular diseases, including tachyarrhythmias, high blood pressure, angina, and heart failure. It is taken by mouth.
Labetalol is a beta blocker, or an antagonist of the β-adrenergic receptors. It is specifically a non-selective antagonist of the β 1-and β 2-adrenergic receptors. Labetalol has intrinsic sympathomimetic activity. It is also an antagonist of the α 1-adrenergic receptor, and hence is additionally an alpha blocker.